BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1399 related articles for article (PubMed ID: 33756229)

  • 1. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.
    Hong LX; Liu L; Lin A; Yan WH
    Int Immunopharmacol; 2021 Jun; 95():107579. PubMed ID: 33756229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region.
    Wang J; Zhang SX; Na JR; Zhang LL; Zhang YH; Chu JJ; Guo L; Yan M; Li YT; Zhou W
    Front Public Health; 2022; 10():1023797. PubMed ID: 36582384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation.
    Huang K; Liu W; Zhou J; Wang Y; Zhang Y; Tang X; Liang J; Bi FF
    Int J Med Sci; 2021; 18(12):2545-2550. PubMed ID: 34104085
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
    Xia J; Zeng Y; Tan Z; Chen T; Hu W; Shuai S; Cao D; Zeng X
    AIDS Rev; 2021 Jun; 23(3):153-163. PubMed ID: 34082440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
    Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
    PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.
    Dao TL; Hoang VT; Gautret P
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):13-25. PubMed ID: 33113040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Bahar B; Jacquot C; Mo YD; DeBiasi RL; Campos J; Delaney M
    J Pediatr; 2020 Dec; 227():31-37.e1. PubMed ID: 32891640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics Associated with Return Visits to the Emergency Department after COVID-19 Diagnosis.
    Husain I; O'Neill J; Mudge R; Bishop A; Soltany KA; Heinen J; Countryman C; Casey D; Cline D
    West J Emerg Med; 2021 Nov; 22(6):1257-1261. PubMed ID: 34787548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
    J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.
    Shaikh A; Zeldis E; Campbell KN; Chan L
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):290-292. PubMed ID: 33055191
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative viral nucleic acid test of induced sputum: an additional criteria for COVID-19 patient's discharge.
    Zheng SL; Sun WL; Sun LN; Zeng XH; Wang QX
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11934-11938. PubMed ID: 33275266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
    Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
    mSphere; 2021 May; 6(3):. PubMed ID: 34011679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    Chen Y; Ke Y; Liu X; Wang Z; Jia R; Liu W; Yang C; Jia L; Wang Y; Han L; Xia X; Zhang S; Wang C
    J Med Virol; 2021 May; 93(5):2782-2789. PubMed ID: 33085103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period.
    Ahmed ZB; Razu MH; Akter F; Rabby MRI; Karmaker P; Khan M
    Biomed Res Int; 2022; 2022():4451144. PubMed ID: 35097117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.